Trials / Completed
CompletedNCT00476892
Multi-centre Randomised Controlled Trial of Pelvic Floor Muscle Training for Prolapse
A Multi-centre Randomised Controlled Trial of a Pelvic Floor Muscle Training Intervention for Women With Pelvic Organ Prolapse
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 448 (actual)
- Sponsor
- Glasgow Caledonian University · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to determine the effectiveness and cost-effectiveness of pelvic floor muscle training in the management of pelvic organ prolapse in women.
Detailed description
Pelvic organ prolapse is a common problem that adversely affects the daily activities and quality of life of many women. Pelvic floor muscle training interventions are commonly used by physiotherapists to manage prolapse. However, a Cochrane review found limited evidence to support the effectiveness of such interventions. Based on the findings of a successful feasibility study, this multi-centre randomised controlled trial will address the paucity of evidence. 556 symptomatic women with diagnosed prolapse will be enrolled in 16 UK centres and 1 New Zealand centre over 16 months and randomised to pelvic floor muscle training plus lifestyle advice, or to receive a lifestyle leaflet only. Principal measures of outcome are: prolapse symptoms, prolapse severity, and subsequent further treatment up to 12 months after trial entry.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Pelvic Floor Muscle Training | Women in the intervention group attend 5 physiotherapy sessions. At each appointment a clinical history is taken, pelvic floor muscle assessment carried out, exercises taught and prescribed, and appropriate lifestyle advice given. At the first of these appointments a detailed explanation of the pelvic anatomy and different types of prolapse is given. |
Timeline
- Start date
- 2007-06-01
- Primary completion
- 2010-07-01
- Completion
- 2011-03-01
- First posted
- 2007-05-22
- Last updated
- 2011-03-23
Locations
28 sites across 4 countries: Australia, Ireland, New Zealand, United Kingdom
Source: ClinicalTrials.gov record NCT00476892. Inclusion in this directory is not an endorsement.